ROSENBLUM MARK J (Exec VP Finance, Interim CFO) purchased 23.3% of their position (28K shares) of DECOY THERAPEUTICS INC. on the open market
Open‑market purchase worth $5.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/31/2022ACC: 0001615219-22-000085
Officer· Exec VP Finance, Interim CFO
Since Sep 2019
+28K
Net shares
Net buyer
$5.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
28K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+28K
Price / share
$0.18
Trade value
$5.04K
% of position
23.3%
5/31/2022
120.32K→148.32K
Total
Net shares
+28K
Net value
$5.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/31/2022 | P · Purchase | +28K | $0.18 | $5.04K | 23.3% | 120.32K | 148.32K |
| Total | +28K | $5.04K | ||||||
Derivative Transactions0
No derivative transactions reported